Penas, Susana Costa http://orcid.org/0000-0001-7696-1957
Resende, José António
Sousa, Amândio Rocha
Carneiro, Ângela Veloso
Reis, Fernando Falcão
Article History
Received: 19 October 2021
Accepted: 5 August 2022
First Online: 5 September 2022
Declarations
:
: This is a retrospective case report with no mandatory approval from the Ethics Committee of our institution.
: Patient was orally informed and written consent for publication of this case report was obtained from the patient. If required, a copy of this consent can be provided.
: Susana Penas: Participation in advisory boards for Alimera, Bayer, Novartis and Roche. Angela Carneiro: Participation in advisory boards for Allergan, Alimera, Bayer, Novartis and Roche. The other authors have no financial disclosures.